Search research articles
Contact Us
Filters
Showing results (51-60 of 105) with videos related to
Page
of 11
Sort By:
Irish Journal of Medical Science
|
August 13, 2016
Pituitary thyroid function and prolactin release following intravenous administration of TRH and pyroglutamyl-histidyl-prolyl-β alanine amide to healthy volunteers
W P Taaffe, R F Lambe, D A O'Kelly, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1990
Pharmacokinetics of falipamil after intravenous administration to humans
W Roth, F W Koss, D Hallinan, et al.
Irish Journal of Medical Science
|
May 1, 1979
Pituitary thyroid function and prolactin release following intravenous administration of TRH and pyroglutamyl-histidyl-prolyl-beta alanine amide to healthy volunteers
W P Taaffe, R F Lambe, D A O'Kelly, et al.
The Canadian Journal of Cardiology
|
September 1, 1985
Left ventricular volume response to exercise in normal and coronary artery disease patients
P D Purves, M A Darragh, V A Gebhardt, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1984
Isosorbide dinitrate plasma concentrations and bioavailability in human subjects after administration of standard oral and sublingual formulations
L F Chasseaud, A Darragh, E Doyle, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1983
Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations
L F Chasseaud, E Doyle, T Taylor, et al.
British Journal of Clinical Pharmacology
|
November 1, 1982
RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability
A Darragh, R Lambe, M Kenny, et al.
British Journal of Anaesthesia
|
April 1, 1983
Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability
C O'Boyle, R Lambe, A Darragh, et al.
Journal of Clinical Pharmacology
|
January 1, 1986
Effect of celiprolol, a new beta 1-alpha 2 blocker, on the cardiovascular response to exercise
F S Caruso, B M Berger, A Darragh, et al.
Biopharmaceutics & Drug Disposition
|
October 1, 1979
Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects
A R Waller, L F Chasseaud, T Taylor, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 105) with videos related to
Sort By:
Page
of 11
Irish Journal of Medical Science
|
August 13, 2016
Pituitary thyroid function and prolactin release following intravenous administration of TRH and pyroglutamyl-histidyl-prolyl-β alanine amide to healthy volunteers
W P Taaffe, R F Lambe, D A O'Kelly, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1990
Pharmacokinetics of falipamil after intravenous administration to humans
W Roth, F W Koss, D Hallinan, et al.
Irish Journal of Medical Science
|
May 1, 1979
Pituitary thyroid function and prolactin release following intravenous administration of TRH and pyroglutamyl-histidyl-prolyl-beta alanine amide to healthy volunteers
W P Taaffe, R F Lambe, D A O'Kelly, et al.
The Canadian Journal of Cardiology
|
September 1, 1985
Left ventricular volume response to exercise in normal and coronary artery disease patients
P D Purves, M A Darragh, V A Gebhardt, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1984
Isosorbide dinitrate plasma concentrations and bioavailability in human subjects after administration of standard oral and sublingual formulations
L F Chasseaud, A Darragh, E Doyle, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1983
Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations
L F Chasseaud, E Doyle, T Taylor, et al.
British Journal of Clinical Pharmacology
|
November 1, 1982
RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability
A Darragh, R Lambe, M Kenny, et al.
British Journal of Anaesthesia
|
April 1, 1983
Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability
C O'Boyle, R Lambe, A Darragh, et al.
Journal of Clinical Pharmacology
|
January 1, 1986
Effect of celiprolol, a new beta 1-alpha 2 blocker, on the cardiovascular response to exercise
F S Caruso, B M Berger, A Darragh, et al.
Biopharmaceutics & Drug Disposition
|
October 1, 1979
Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects
A R Waller, L F Chasseaud, T Taylor, et al.
Page
of 11